Saved in:
| Main Author: | Ohe, Masashi |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2026
|
| Online Access: | https://doi.org/10.5281/zenodo.20204754 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Identification of drug repurposing candidates for the treatment of polycystic kidney disease
by: Alina Meyer, et al.
Published: (2026)
by: Alina Meyer, et al.
Published: (2026)
Drug-disease networks and drug repurposing
by: Polanco, Austin, et al.
Published: (2025)
by: Polanco, Austin, et al.
Published: (2025)
A review on drug repurposing applicable to obesity
by: Feng Chen, et al.
Published: (2024)
by: Feng Chen, et al.
Published: (2024)
The eyes of the beholder: Perceived barriers to successful drug repurposing
by: Zsuzsanna Ida Petykó, et al.
Published: (2025)
by: Zsuzsanna Ida Petykó, et al.
Published: (2025)
Hantavirus Infections
by: Camilo Guzmán T
Published: (2017)
by: Camilo Guzmán T
Published: (2017)
Network-based drug repurposing for MYH9-related nephritis
by: Ali, Muhammad, et al.
Published: (2026)
by: Ali, Muhammad, et al.
Published: (2026)
Network-driven discovery of repurposable drugs targeting hallmarks of aging
by: Gross, Bnaya, et al.
Published: (2025)
by: Gross, Bnaya, et al.
Published: (2025)
Statins as anti‐tumor agents: A paradigm for repurposed drugs
by: Sneha Tripathi, et al.
Published: (2024)
by: Sneha Tripathi, et al.
Published: (2024)
Central nervous system infection with Hantavirus in a solid organ transplant patient
by: Xing‐song Qin, et al.
Published: (2024)
by: Xing‐song Qin, et al.
Published: (2024)
The mouse to man conundrum: Revisiting an old lung injury model to study repurposed drugs for COVID‐19 treatment
by: Andreas Ronit, et al.
Published: (2024)
by: Andreas Ronit, et al.
Published: (2024)
Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases
by: Imogen R. Walpole, et al.
Published: (2024)
by: Imogen R. Walpole, et al.
Published: (2024)
Hantavirus and criminality: disease and family
by: Ana Cláudia Pereira Terças Trettel
Published: (2020)
by: Ana Cláudia Pereira Terças Trettel
Published: (2020)
Potential COVID‐19 remedies from repurposed drugs and herbal small RNAs
by: Yang Yang, et al.
Published: (2024)
by: Yang Yang, et al.
Published: (2024)
Pharmacoepidemiology evaluation of bumetanide as a potential candidate for drug repurposing for Alzheimer's disease
by: Jasmine Morales, et al.
Published: (2024)
by: Jasmine Morales, et al.
Published: (2024)
A computer‐aided drug repurposing: the antibacterial agents targeting GroEL
by: Dongdong Zhang, et al.
Published: (2025)
by: Dongdong Zhang, et al.
Published: (2025)
Novel drug design and repurposing: An opportunity to improve translational research in cardiovascular diseases?
by: José S. Rodríguez‐Zavala, et al.
Published: (2024)
by: José S. Rodríguez‐Zavala, et al.
Published: (2024)
In vitro and in silico investigation of FDA‐approved drugs to be repurposed against Alzheimer's disease
by: Didem Akkaya, et al.
Published: (2024)
by: Didem Akkaya, et al.
Published: (2024)
Single‐cell digital twins identify drug targets and repurposable medicine in Alzheimer’s disease
by: Yunxiao Ren, et al.
Published: (2025)
by: Yunxiao Ren, et al.
Published: (2025)
Unlocking reproducible transcriptomic signatures for acute myeloid leukaemia: Integration, classification and drug repurposing
by: Haoran Chen, et al.
Published: (2024)
by: Haoran Chen, et al.
Published: (2024)
Teaching an old drug new tricks: Regulatory insights for the repurposing of hemin in cardiovascular disease
by: Ashley L. Eadie, et al.
Published: (2024)
by: Ashley L. Eadie, et al.
Published: (2024)
Hantavirus y otros virus hemorrágicos
by: SALIM MATTAR
Published: (2007)
by: SALIM MATTAR
Published: (2007)
Hantaviruses in the Americas: A growing problem
by: James N. Mills
Published: (2004)
by: James N. Mills
Published: (2004)
Unveiling the impacts of land use on the phylogeography of zoonotic New World Hantaviruses
by: Gabriel E. García‐Peña, et al.
Published: (2024)
by: Gabriel E. García‐Peña, et al.
Published: (2024)
હન્ટાવાયરસ (Hantavirus): ઉંદરથી ફેલાતો જીવલેણ રોગ
by: ડૉ. સેજલબેન પી. આંટીયા*, ડૉ. કૃતાર્થ માલવિયા, ડૉ.પાર્થ જયસ્વાલ, ડૉ. યશ ત્રિવેદી, ડૉ. પૂજીથા કોન્ગારા
Published: (2026)
by: ડૉ. સેજલબેન પી. આંટીયા*, ડૉ. કૃતાર્થ માલવિયા, ડૉ.પાર્થ જયસ્વાલ, ડૉ. યશ ત્રિવેદી, ડૉ. પૂજીથા કોન્ગારા
Published: (2026)
Research on repurposed antivirals currently available in Colombia as treatment alternatives for COVID-19
by: David Gómez-Ríos
Published: (2021)
by: David Gómez-Ríos
Published: (2021)
Investigating novel compounds to combat Multidrug-Resistant bacterial infections
by: Jeetendra Kumar Prajapati, et al.
Published: (2025)
by: Jeetendra Kumar Prajapati, et al.
Published: (2025)
Representações sobre personagens femininos no filme de animação Meu Malvado Favorito 2
by: Ana Paula Trofino Ohe
Published: (2021)
by: Ana Paula Trofino Ohe
Published: (2021)
Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation
by: Reina Tonegawa‐Kuji, et al.
Published: (2025)
by: Reina Tonegawa‐Kuji, et al.
Published: (2025)
Nanotechnology‐driven strategies to enhance the treatment of drug‐resistant bacterial infections
by: Junjie Zhang, et al.
Published: (2024)
by: Junjie Zhang, et al.
Published: (2024)
Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models
by: Jindrich Cinatl, et al.
Published: (2024)
by: Jindrich Cinatl, et al.
Published: (2024)
Identificación de Hantavirus Andes en Rattus norvegicus
by: J Fernández
Published: (2008)
by: J Fernández
Published: (2008)
DrugMCTS: a drug repurposing framework combining multi-agent, RAG and Monte Carlo Tree Search
by: Yang, Zerui, et al.
Published: (2025)
by: Yang, Zerui, et al.
Published: (2025)
Data from cell lines of the project "Optimisation of PK/PD parameters of a repurposed drug therapy for patients with SMA".
by: Artero, Ruben, et al.
Published: (2026)
by: Artero, Ruben, et al.
Published: (2026)
Structure‐based virtual screening and drug repurposing studies indicate potential inhibitors of bovine papillomavirus E6 oncoprotein
by: Lucas Alexandre Barbosa de Oliveira Santos, et al.
Published: (2024)
by: Lucas Alexandre Barbosa de Oliveira Santos, et al.
Published: (2024)
PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies
by: Nada Abla, et al.
Published: (2024)
by: Nada Abla, et al.
Published: (2024)
Translating high throughput screens in C elegans and microglia to humans with Medicare data to repurpose drugs to treat Alzheimer’s disease
by: Rachel R Litke, et al.
Published: (2024)
by: Rachel R Litke, et al.
Published: (2024)
Pan‐cancer analysis and oncogenic implications of MGAM and MGAM2: Toward precision oncology and drug repurposing in colorectal cancer
by: Rawaa Chasib Mezher, et al.
Published: (2025)
by: Rawaa Chasib Mezher, et al.
Published: (2025)
Hantavirus como agentes emergentes de importancia en Suramérica
by: Andrés F. Londoño
Published: (2011)
by: Andrés F. Londoño
Published: (2011)
Pharmacokinetic modelling to enable early attrition of repurposed antiviral drug combination candidates with a high likelihood of failure in COVID‐19
Published: (2024)
Published: (2024)
Hantavirus Gc glycoprotein: Evidence for a class ll fusion protein
by: Gonzalez Wong, Angel
Published: (2005)
by: Gonzalez Wong, Angel
Published: (2005)
Similar Items
-
Identification of drug repurposing candidates for the treatment of polycystic kidney disease
by: Alina Meyer, et al.
Published: (2026) -
Drug-disease networks and drug repurposing
by: Polanco, Austin, et al.
Published: (2025) -
A review on drug repurposing applicable to obesity
by: Feng Chen, et al.
Published: (2024) -
The eyes of the beholder: Perceived barriers to successful drug repurposing
by: Zsuzsanna Ida Petykó, et al.
Published: (2025) -
Hantavirus Infections
by: Camilo Guzmán T
Published: (2017)